Clinical efficacy and safety: cardiovascular system

  • Email
  • Help

The European Medicines Agency’s scientific guidelines on the clinical evaluation of human medicines used in conditions affecting the cardiovascular system help medicine developers prepare marketing authorisation applications.

If you have comments on a document which is open for consultation, use the form for submission of comments on scientific guidelines.

Please submit your comments to the following email address: cvswpsecretariat@ema.europa.eu.

For a complete list of scientific guidelines currently open for consultation, see Public consultations.

 
Hypertension

Guidelines

 
Lipid disorders

Guidelines

 
Pulmonary arterial hypertenstion

Guidelines

 
Arrythmias

Guidelines

 
Venous thromboembolism

Guidelines

 

Concept papers

 
Heart failure

Guidelines

 
Coronary artery disease

Guidelines

 
Other

Guidelines


Reflection papers


Position statements

How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more

Related content